Mobia Medical’s (MOBI) Buy Rating Reiterated at BTIG Research

Posted by Brenda Bartman on Oct 23rd, 2026

BTIG Research restated their buy rating on shares of Mobia Medical (NASDAQ:MOBI – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $19.00 price target on the stock.

MOBI has been the subject of several other reports. Weiss Ratings began coverage on shares of Mobia Medical in a research report on Wednesday, August 12th. They set a “sell (e-)” rating for the company. JPMorgan Chase & Co. raised their price target on shares of Mobia Medical from $15.00 to $17.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. Five analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $20.75.

Get Our Latest Analysis on Mobia Medical

Mobia Medical Trading Up 9.8%

MOBI stock opened at $10.58 on Tuesday. The company has a debt-to-equity ratio of 0.04, a current ratio of 13.28 and a quick ratio of 12.80. The company has a 50-day simple moving average of $10.08. Mobia Medical has a 12 month low of $8.03 and a 12 month high of $15.29.

Mobia Medical (NASDAQ:MOBI – Get Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($1.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.27). The company had revenue of $13.51 million during the quarter. The business’s revenue was up 102.4% on a year-over-year basis. Sell-side analysts forecast that Mobia Medical will post -2.63 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Casey Tansey purchased 35,572 shares of the company’s stock in a transaction on Thursday, August 13th. The stock was acquired at an average cost of $11.51 per share, for a total transaction of $409,433.72. Following the completion of the transaction, the director directly owned 268,904 shares in the company, valued at approximately $3,095,085.04. The trade was a 15.25% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Insiders have bought a total of 87,000 shares of company stock worth $1,016,367 over the last ninety days.

Institutional Trading of Mobia Medical

Several institutional investors have recently added to or reduced their stakes in the stock. State Street Corp purchased a new stake in Mobia Medical in the second quarter valued at approximately $735,000. Citadel Advisors LLC purchased a new position in shares of Mobia Medical during the second quarter worth $670,000. Finally, Readystate Asset Management LP acquired a new stake in shares of Mobia Medical in the second quarter valued at $134,000.

Mobia Medical Company Profile

(Get Free Report)

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.